Market Tracker

06/28 5:16pm ET

Boston Scientific Corp (NYSE:BSX)

22.35
Delayed Data
As of 4:02pm ET
 +0.37 / +1.68%
Today’s Change
14.18
Today|||52-Week Range
23.35
+21.20%
Year-to-Date
GW Pharmaceuticals (GWPH) Catches Eye: Stock Gains 6.2%
9:22am / Zacks.com - Paid Partner Content
GNC Gains as Buyout Rumors of Vitamin Shoppe Resurface
Jun 23 / Zacks.com - Paid Partner Content
Akers Biosciences Signs Distribution Agreement, Shares Rally
8:30am / Zacks.com - Paid Partner Content
Qiagen's Q1 Results Hit by Currency, Competition Rife
Jun 21 / Zacks.com - Paid Partner Content
Medtronic Acquires HeartWare With Some Activist Inspiration
Jun 27 / TheStreet.com - Paid Partner Content
Boston Scientific: NICE Backs GreenLight XPS for BPH Cure
Jun 15 / Zacks.com - Paid Partner Content
Genomic Health: Can the Liquid Biopsy Test Boost Margins?
Jun 24 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close21.98
Today’s open22.20
Day’s range22.10 - 22.37
Volume14,216,803
Average volume (3 months)10,370,702
Market cap$29.8B
Dividend yield--
Data as of 4:02pm ET, 06/28/2016

Growth & Valuation

Earnings growth (last year)-100.00%
Earnings growth (this year)+17.41%
Earnings growth (next 5 years)+11.00%
Revenue growth (last year)+1.25%
P/E ratioNM
Price/Sales3.34
Price/Book4.68

Competitors

 Today’s
change
Today’s
% change
BDXBecton Dickinson and...+1.07+0.66%
ZBHZimmer Biomet Holdin...+1.98+1.72%
EWEdwards Lifesciences...+0.44+0.47%
SYKStryker Corp+1.56+1.36%
Data as of 4:02pm ET, 06/28/2016

Financials

Next reporting dateJuly 21, 2016
EPS forecast (this quarter)$0.26
Annual revenue (last year)$7.4B
Annual profit (last year)-$239.0M
Net profit margin-3.23%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael F. Mahoney
Executive Vice President-
Operations
Edward Mackey
Corporate headquarters
Marlborough, Massachusetts

Forecasts